SM
SAGE

Sabby Management’s Sage Therapeutics SAGE Stock Holding History

Sabby Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,379
Closed -$244K – 254
2017
Q1 		$240K Buy
+3,379
New +$198K 0.01% 212
2016
Q3 		– Sell
-68,950
Closed -$2.81M – 334
2016
Q2 		$2.08M Sell
68,950
-31,050
-31% -$1.04M 0.11% 107
2016
Q1 		$3.21M Buy
100,000
+91,877
+1,131% +$3.23M 0.16% 66
2015
Q4 		$474K Sell
8,123
-31,896
-80% -$1.58M 0.03% 240
2015
Q3 		$1.69M Buy
40,019
+14,939
+60% +$921K 0.07% 178
2015
Q2 		$1.83M Buy
+25,080
New +$1.61M 0.07% 172

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return